Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients
- 30 August 2023
- journal article
- research article
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 9 (10) , 2122-2131
Abstract
No abstract availableKeywords
Funding Information
- NHLBI
- Gilead Sciences Inc
- Boston Scientific Corp
This publication has 49 references indexed in Scilit:
- Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trialsBMC Cardiovascular Disorders, 2013
- Reduction in Inappropriate Therapy and Mortality through ICD ProgrammingNew England Journal of Medicine, 2012
- Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ releaseNature Medicine, 2011
- Atrial Fibrillation and Heart FailureCirculation, 2009
- Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure—COMETAmerican Heart Journal, 2005
- Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN)The American Journal of Cardiology, 2004
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988